Discover
MAIA
MAIA Biotechnology, Inc.
1.43
1700 x 1.42
5000 x 1.51
bid
ask
-
0.01
0.69%
3350 @ 04:00 PM
1.43 +0.00 (0.00%)
| Ytd | -6.54% | |
| 1y | -25.52% |
1.40
day range
1.46
0.87
52 week range
3.19
| Open | 1.40 | Prev Close | 1.44 | Low | 1.40 | High | 1.46 | Mkt Cap | 86.95M |
| Vol | 255.73K | Avg Vol | 745.35K | EPS | -0.68 | P/E | N/A | Forward P/E | -1.25 |
| Beta | 0.34 | Short Ratio | 10.99 | Inst. Own | 7.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 1.33 | 200-d Avg | 1.49 | 1yr Est | 12.63 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2023-02-21 | Noble Capital Markets | Upgrade | Outperform |
Profile
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-03-13 | CHAOUKI STEVEN M | Director | 88.89K | Purchase |
| 2024-12-12 | GUERRERO RAMIRO | Director | 514.97K | Purchase |
| 2024-04-24 | LOUIE NGAR YEE | Director | 1.17M | Purchase |
| 2024-10-31 | LUPUT CRISTIAN | Director | 389.48K | Purchase |
| 2023-04-26 | MCGUIRE JOSEPH F | Chief Financial Officer | 9.40K | Purchase |
| 2024-10-31 | SMITH STAN V | Director | 0.00 | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Group Inc | 566.37K | 1.12M | 2.24% |
| 2024-09-29 | Halter Ferguson Financial Inc. | 376.71K | 742.13K | 1.49% |
| 2024-09-29 | Geode Capital Management, LLC | 192.56K | 379.35K | 0.76% |
| 2024-09-29 | Blackrock Inc. | 79.73K | 157.06K | 0.31% |
| 2024-09-29 | Centric Wealth Management | 68.22K | 134.39K | 0.27% |
| 2024-09-29 | Bridgeway Capital Management, Inc. | 45.70K | 90.03K | 0.18% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 401.59K | 791.13K | 1.59% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 153.39K | 302.17K | 0.61% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 108.76K | 214.25K | 0.43% |
| 2024-09-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 45.70K | 90.03K | 0.18% |
| 2024-10-30 | Fidelity Total Market Index Fund | 36.05K | 71.02K | 0.14% |
| 2024-10-30 | iShares Micro Cap ETF | 29.16K | 57.45K | 0.12% |